Who owns the GLINX trademark?

The GLINX trademark is owned by Shanghai GlinX Biotechnology Co., Ltd..

What class is the GLINX trademark registered in?

The GLINX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for GLINX?

The USPTO serial number for GLINX is 79434325.

What is the registration number for GLINX?

GLINX is registered under USPTO registration number 8497630.

Sealvo

Home Search: GLINXGLINX #79434325

Back

Updated Oct 14, 2026·27 searches this week

View on USPTO TSDR Find similar marks

GLI

USPTO Trademark Record

REGISTERED

GLINX

SN 79434325·Reg 8497630·Filed May 20, 2025

Owner Shanghai GlinX Biotechnology Co., Ltd.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

GLINX (Serial No. 79434325), Registration No. 8497630, is a registered US trademark filed on May 20, 2025 by Shanghai GlinX Biotechnology Co., Ltd.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: October 13, 2032

Mark Intelligence

GLINX (Reg. #8497630) is a registered US trademark that has been protecting its owner, Shanghai GlinX Biotechnology Co., Ltd., since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

May 20, 2025

SERIAL

79434325

REG#

8497630

REGISTERED

Oct 13, 2026

Filing Information

StatusREGISTERED

Filing DateMay 20, 2025

Serial Number79434325

Registration No.8497630

Registration DateOct 13, 2026

Status DateOct 13, 2026

Published for OppositionAug 25, 2026

Filing Basis & Declarations

Trademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

25 events

REGISTERED-PRINCIPAL REGISTER

Oct 13, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Oct 13, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Aug 25, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 25, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Aug 20, 2026

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 19, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Aug 05, 2026

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Aug 05, 2026

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 27, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Jul 25, 2026

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jul 25, 2026

EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jul 25, 2026

EXAMINER'S AMENDMENT ENTERED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 25, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 15, 2026

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 15, 2026

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 15, 2026

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Jan 01, 2026

REFUSAL PROCESSED BY IB

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Dec 15, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

REFUSAL PROCESSED BY MPU

Dec 14, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Oct 15, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Oct 14, 2025

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Oct 11, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 10, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Oct 10, 2025

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Oct 09, 2025

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Shanghai GlinX Biotechnology Co., Ltd.

Additional USPTO filings from the same owner.

GLI

GLINX

79450744

Shanghai GlinX Biotechnology Co., Ltd.

PENDING

Other Marks by Miki Motohashi Iino

Additional USPTO filings handled by the same attorney of record.

KEE

KEEPER OF LIGHT

99792254

REGISTERED

HOO

HOOLOO

99552325

REGISTERED

MY3

MY3DSHADOW

99705180

REGISTERED

KAT

KATSUMIDORI SUSHI

99547922

REGISTERED

GLINX

Run a conflict check

Other Marks by Shanghai GlinX Biotechnology Co., Ltd.

Other Marks by Miki Motohashi Iino

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company